Market Overview

APHRIA SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aphria Inc. - APHA


ClaimsFiler, a FREE shareholder information service, reminds investors
that they have until February 4, 2019 to file lead plaintiff
applications in a securities class action lawsuit against Aphria Inc.
(NYSE:APHA), if they purchased the Company's securities between July
17, 2018 and December 4, 2018, inclusive (the "Class Period"). This
action is pending in the United States District Court for the Southern
District of New York.

Get Help

Aphria investors should visit us at
or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are
available to discuss your legal options.

About the Lawsuit

Aphria and certain of its executives are charged with failing to
disclose material information during the Class Period, violating federal
securities laws.

On December 3, 2018, Hindenburg Research reported in an article entitled
"Aphria: A Shell Game with a Cannabis Business on the Side," that an
extensive investigation revealed that "Aphria is part of a scheme
orchestrated by a network of insiders to divert funds away from
shareholders into their own pockets" and detailing the questionable
value of its investments.

On this news, the price of Aphria's shares plummeted.

The case is Gloschat v. Aphria Inc. et al, 18-cv-11427

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to
help retail investors recover their share of billions of dollars from
securities class action settlements. At, investors can:
(1) register for free to gain access to information and settlement
websites for various securities class action cases so they can timely
submit their own claims; (2) upload their portfolio transactional data
to be notified about relevant securities cases in which they may have a
financial interest; and (3) submit inquiries to the Kahn Swick & Foti,
LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit

View Comments and Join the Discussion!